SCHEMBL22041599

SCHEMBL22041599

O=C(Oc1c(Br)c(Br)cc2cc(C(=O)O)c(=O)oc12)c1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 15/20 0.52
▸ HPGD P15428 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ F12 P00748 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 2/20 0.41
▸ CA12 O43570 2/20 0.40
▸ CA1 P00915 2/20 0.40
▸ CA3 P07451 2/20 0.40
▸ CA4 P22748 2/20 0.40
▸ CA6 P23280 2/20 0.40
▸ CA5A P35218 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041604 0.87 GPR35 (0.55) GPR35HPGDPOLBALDH1A1LMNA
SCHEMBL22041612 0.85 GPR35 (0.58) GPR35POLBMAOBCA12CA1
SCHEMBL22041635 0.83 GPR35 (0.54) GPR35HPGDALDH1A1LMNAMAOA
SCHEMBL22041589 0.83 GPR35 (0.50) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041600 0.83 GPR35 (0.52) GPR35HPGDALDH1A1LMNAMAOA
SCHEMBL22041935 0.82 GPR35 (0.51) GPR35HPGDPOLBF12ALDH1A1
SCHEMBL22041620 0.81 GPR35 (0.53) GPR35HPGDUSP2CASP1CASP7
SCHEMBL22041622 0.80 GPR35 (0.51) GPR35HPGDALDH1A1LMNAMAOA
SCHEMBL22041625 0.79 GPR35 (0.56) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041626 0.79 GPR35 (0.64) GPR35HPGDUSP2POLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback